AMRO D: Cost effectiveness results for Maternal and Neonatal Health
This Table provides summary results of the total population-level costs, effects and cost-effectiveness for the selected WHO sub-region and risk factor / disease for the year 2000.
KEY
I$ - International Dollars
Program Costs include costs of administration, media, training etc
Patient Costs include costs of hospital visits, drugs, etc
-
Summary
Summary of the methodologies used in the analysis -
Published research report
pdf, 167kb -
Excel Spreadsheet
xls, 93kb
Download this table in excel
| Interventions:Codes_and_Descriptions | Coverage | Cost per year (I$, millions) per one million_population [i.e. cost per capita] | % Program costs | % Patient costs | DALYs averted per year per one million_population | Average Cost per DALY averted | Incremental Cost per DALY averted |
| MNH-1: Community newborn care package | 50% | 0.08 | 32% | 68% | 3,110 | 27 | Dominated |
| MNH-2: Support for breastfeeding mothers | 50% | 0.09 | 31% | 69% | 6,500 | 13 | Dominated |
| MNH-3: Pre-eclampsia screening | 50% | 0.04 | 23% | 77% | 1,415 | 29 | Dominated |
| MNH-4: Tetanus toxoid | 50% | 0.05 | 20% | 80% | 2,864 | 17 | Dominated |
| MNH-5: Screening & treatment of asymptomatic bacteriuria | 50% | 0.03 | 33% | 67% | 873 | 33 | Dominated |
| MNH-6: Screening & treatment of syphilis | 50% | 0.03 | 30% | 70% | 691 | 46 | Dominated |
| MNH-7: Normal delivery by a skilled attendant | 50% | 0.12 | 11% | 89% | 2,911 | 40 | Dominated |
| MNH-8: Community-based case management for neonatal pneumonia | 50% | 0.00 | 76% | 24% | 2,792 | 1 | Dominated |
| MNH-9: Normal delivery by a skilled attendant + Tetanus Toxoid | 50% | 0.16 | 9% | 91% | 4,258 | 37 | Dominated |
| MNH-10: Management of maternal sepsis | 50% | 0.10 | 3% | 97% | 70 | 1,424 | Dominated |
| MNH-11: Management of severe neonatal asphyxia | 50% | 0.03 | 41% | 59% | 234 | 134 | Dominated |
| MNH-12: Management of serious newborn infections | 50% | 0.11 | 12% | 88% | 3,493 | 32 | Dominated |
| MNH-13: Management of very low birth weight babies | 50% | 0.04 | 29% | 71% | 2,104 | 21 | Dominated |
| MNH-14: Manangement of neonatal jaundice | 50% | 0.03 | 44% | 56% | 61 | 481 | Dominated |
| MNH-15: Tetanus toxoid + Pre-eclampsia screening | 50% | 0.07 | 15% | 85% | 4,289 | 16 | Dominated |
| MNH-16: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 50% | 0.07 | 19% | 81% | 5,172 | 14 | Dominated |
| MNH-17: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 50% | 0.08 | 22% | 78% | 5,836 | 13 | Dominated |
| MNH-18: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 50% | 0.17 | 11% | 89% | 5,145 | 34 | Dominated |
| MNH-19: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 50% | 0.16 | 11% | 89% | 7,227 | 22 | Dominated |
| MNH-20: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 50% | 0.31 | 5% | 95% | 8,225 | 38 | Dominated |
| MNH-21: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 50% | 0.21 | 9% | 91% | 5,229 | 40 | Dominated |
| MNH-22: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 50% | 0.21 | 11% | 89% | 4,630 | 45 | Dominated |
| MNH-23: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 50% | 0.29 | 6% | 94% | 7,455 | 39 | Dominated |
| MNH-24: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 50% | 0.20 | 7% | 93% | 5,743 | 35 | Dominated |
| MNH-25: Management of vLBW + Management of serious newborn infections | 50% | 0.20 | 8% | 92% | 5,619 | 36 | Dominated |
| MNH-26: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 50% | 0.22 | 7% | 93% | 5,856 | 38 | Dominated |
| MNH-27: ENC | 50% | 0.24 | 8% | 92% | 5,926 | 41 | Dominated |
| MNH-28: ENC + Management of maternal sepsis | 50% | 0.36 | 6% | 94% | 5,988 | 61 | Dominated |
| MNH-29: Community newborn care package + Community-based pneumonia | 50% | 0.10 | 44% | 56% | 5,928 | 17 | Dominated |
| MNH-30: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 50% | 0.19 | 14% | 86% | 7,182 | 26 | Dominated |
| MNH-31: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 50% | 0.22 | 11% | 89% | 8,369 | 27 | Dominated |
| MNH-32: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 50% | 0.26 | 10% | 90% | 7,221 | 36 | Dominated |
| MNH-33: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 50% | 0.29 | 10% | 90% | 10,102 | 29 | Dominated |
| MNH-34: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 50% | 0.31 | 8% | 92% | 7,578 | 41 | Dominated |
| MNH-35: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 50% | 0.34 | 8% | 92% | 10,296 | 33 | Dominated |
| MNH-36: Community newborn care package + Tetanus Toxoid | 50% | 0.13 | 28% | 72% | 5,975 | 22 | Dominated |
| MNH-37: Community-based pneumonia + Tetanus Toxoid | 50% | 0.05 | 23% | 77% | 5,656 | 9 | Dominated |
| MNH-38: Community-based pneumonia + ANC | 50% | 0.08 | 24% | 76% | 8,628 | 9 | Dominated |
| MNH-39: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 50% | 0.15 | 36% | 64% | 8,792 | 17 | Dominated |
| MNH-40: Support for breastfeeding mothers + Tetanus toxoid | 50% | 0.13 | 27% | 73% | 9,365 | 14 | Dominated |
| MNH-41: Community newborn care package + ANC | 50% | 0.16 | 27% | 73% | 8,946 | 18 | Dominated |
| MNH-42: Community newborn care package + ANC + Community-based pneumonia | 50% | 0.18 | 35% | 65% | 11,764 | 15 | Dominated |
| MNH-43: Community newborn care package + ANC + Community-based pneumonia + SMNC | 50% | 0.31 | 26% | 74% | 16,965 | 18 | Dominated |
| MNH-44: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 50% | 0.22 | 34% | 66% | 13,867 | 16 | Dominated |
| MNH-45: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 50% | 0.51 | 18% | 82% | 18,648 | 27 | Dominated |
| MNH-46: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 50% | 0.36 | 26% | 74% | 19,069 | 19 | Dominated |
| MNH-47: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 50% | 0.35 | 23% | 77% | 18,152 | 19 | Dominated |
| MNH-48: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 50% | 0.48 | 18% | 82% | 21,349 | 23 | Dominated |
| MNH-49: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 50% | 0.51 | 17% | 83% | 22,119 | 23 | Dominated |
| MNH-50: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 50% | 0.62 | 14% | 86% | 22,244 | 28 | Dominated |
| MNH-51: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 50% | 0.39 | 24% | 76% | 20,256 | 19 | Dominated |
| MNH-52: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 50% | 0.17 | 34% | 66% | 11,100 | 16 | Dominated |
| MNH-53: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 50% | 0.59 | 17% | 83% | 24,078 | 25 | Dominated |
| MNH-54: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 50% | 0.51 | 17% | 83% | 22,119 | 23 | Dominated |
| MNH-55: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 50% | 0.15 | 26% | 74% | 8,282 | 19 | Dominated |
| MNH-56: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.70 | 13% | 87% | 24,251 | 29 | Dominated |
| MNH-57: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 50% | 0.61 | 14% | 86% | 25,316 | 24 | Dominated |
| MNH-58: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 50% | 0.51 | 16% | 84% | 22,204 | 23 | Dominated |
| MNH-59: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 50% | 0.55 | 15% | 85% | 22,159 | 25 | Dominated |
| MNH-60: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 50% | 0.53 | 17% | 83% | 22,491 | 23 | Dominated |
| MNH-61: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 50% | 0.72 | 14% | 86% | 28,045 | 26 | Dominated |
| MNH-62: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 50% | 0.85 | 12% | 88% | 31,243 | 27 | Dominated |
| MNH-63: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 50% | 0.26 | 18% | 82% | 8,255 | 31 | Dominated |
| MNH-64: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.69 | 13% | 87% | 23,587 | 29 | Dominated |
| MNH-65: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 50% | 0.85 | 12% | 88% | 31,243 | 27 | Dominated |
| MNH-66: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 50% | 0.79 | 12% | 88% | 28,085 | 28 | Dominated |
| MNH-67: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 50% | 0.76 | 13% | 87% | 28,130 | 27 | Dominated |
| MNH-68: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 50% | 0.93 | 11% | 89% | 31,282 | 30 | Dominated |
| MNH-69: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 50% | 0.89 | 12% | 88% | 31,327 | 28 | Dominated |
| MNH-70: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 50% | 0.90 | 12% | 88% | 31,614 | 29 | Dominated |
| MNH-71: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 50% | 0.97 | 11% | 89% | 31,638 | 31 | Dominated |
| MNH-72: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 50% | 0.96 | 11% | 89% | 31,367 | 31 | Dominated |
| MNH-73: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 50% | 1.01 | 10% | 90% | 31,723 | 32 | Dominated |
| MNH-74: Community newborn care package + Tetanus Toxoid + SMNC | 50% | 0.26 | 19% | 81% | 11,224 | 23 | Dominated |
| MNH-75: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 50% | 0.28 | 23% | 77% | 11,072 | 25 | Dominated |
| MNH-76: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 50% | 0.28 | 24% | 76% | 14,041 | 20 | Dominated |
| MNH-77: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 50% | 0.28 | 18% | 82% | 10,562 | 26 | Dominated |
| MNH-78: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 50% | 0.30 | 23% | 77% | 13,380 | 22 | Dominated |
| MNH-79: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 50% | 0.41 | 12% | 88% | 14,530 | 28 | Dominated |
| MNH-80: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 50% | 0.43 | 16% | 84% | 17,347 | 25 | Dominated |
| MNH-81: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 50% | 0.41 | 13% | 87% | 17,499 | 24 | Dominated |
| MNH-82: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 50% | 0.43 | 16% | 84% | 17,347 | 25 | Dominated |
| MNH-83: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 50% | 0.43 | 17% | 83% | 20,316 | 21 | Dominated |
| MNH-84: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 50% | 0.34 | 21% | 79% | 17,536 | 19 | Dominated |
| MNH-85: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 50% | 0.50 | 15% | 85% | 21,503 | 23 | Dominated |
| MNH-86: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 50% | 0.41 | 18% | 82% | 17,576 | 23 | Dominated |
| MNH-87: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 50% | 0.38 | 19% | 81% | 17,621 | 21 | Dominated |
| MNH-88: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 50% | 0.45 | 16% | 84% | 17,660 | 25 | Dominated |
| MNH-89: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.82 | 11% | 89% | 27,554 | 30 | Dominated |
| MNH-90: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.82 | 11% | 89% | 28,218 | 29 | Dominated |
| MNH-91: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 50% | 0.87 | 11% | 89% | 28,574 | 31 | Dominated |
| MNH-92: Community newborn care package | 80% | 0.15 | 39% | 61% | 4,976 | 29 | Dominated |
| MNH-93: Support for breastfeeding mothers | 80% | 0.15 | 37% | 63% | 10,401 | 15 | Dominated |
| MNH-94: Pre-eclampsia screening | 80% | 0.08 | 33% | 67% | 2,264 | 34 | Dominated |
| MNH-95: Tetanus toxoid | 80% | 0.10 | 26% | 74% | 4,583 | 22 | Dominated |
| MNH-96: Screening & treatment of asymptomatic bacteriuria | 80% | 0.06 | 41% | 59% | 1,398 | 45 | Dominated |
| MNH-97: Screening & treatment of syphilis | 80% | 0.07 | 38% | 62% | 1,106 | 61 | Dominated |
| MNH-98: Normal delivery by a skilled attendant | 80% | 0.20 | 17% | 83% | 4,658 | 43 | Dominated |
| MNH-99: Community-based case management for neonatal pneumonia | 80% | 0.00 | 70% | 30% | 4,467 | 1 | Dominated |
| MNH-100: Normal delivery by a skilled attendant + Tetanus Toxoid | 80% | 0.28 | 13% | 87% | 6,813 | 40 | Dominated |
| MNH-101: Management of maternal sepsis | 80% | 0.17 | 2% | 98% | 112 | 1,507 | Dominated |
| MNH-102: Management of severe neonatal asphyxia | 80% | 0.07 | 52% | 48% | 374 | 175 | Dominated |
| MNH-103: Management of serious newborn infections | 80% | 0.20 | 17% | 83% | 5,589 | 36 | Dominated |
| MNH-104: Management of very low birth weight babies | 80% | 0.09 | 39% | 61% | 3,366 | 26 | Dominated |
| MNH-105: Manangement of neonatal jaundice | 80% | 0.06 | 55% | 45% | 97 | 636 | Dominated |
| MNH-106: Tetanus toxoid + Pre-eclampsia screening | 80% | 0.14 | 20% | 80% | 6,862 | 20 | Dominated |
| MNH-107: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 80% | 0.14 | 23% | 77% | 8,275 | 17 | Dominated |
| MNH-108: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 80% | 0.15 | 25% | 75% | 9,338 | 16 | Dominated |
| MNH-109: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 80% | 0.30 | 15% | 85% | 8,231 | 36 | Dominated |
| MNH-110: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 80% | 0.28 | 15% | 85% | 11,563 | 25 | Dominated |
| MNH-111: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 80% | 0.55 | 7% | 93% | 13,160 | 42 | Dominated |
| MNH-112: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 80% | 0.35 | 13% | 87% | 8,367 | 41 | Dominated |
| MNH-113: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 80% | 0.35 | 11% | 89% | 7,407 | 48 | Dominated |
| MNH-114: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 80% | 0.51 | 9% | 91% | 11,928 | 43 | Dominated |
| MNH-115: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 80% | 0.36 | 10% | 90% | 9,189 | 39 | Dominated |
| MNH-116: Management of vLBW + Management of serious newborn infections | 80% | 0.36 | 11% | 89% | 8,990 | 40 | Dominated |
| MNH-117: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 80% | 0.39 | 10% | 90% | 9,370 | 42 | Dominated |
| MNH-118: Emergency neonatal care | 80% | 0.42 | 10% | 90% | 9,482 | 44 | Dominated |
| MNH-119: ENC + Management of maternal sepsis | 80% | 0.62 | 7% | 93% | 9,581 | 65 | Dominated |
| MNH-120: Community newborn care package + Community-based pneumonia | 80% | 0.14 | 34% | 66% | 9,484 | 14 | Dominated |
| MNH-121: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 80% | 0.34 | 17% | 83% | 11,491 | 29 | Dominated |
| MNH-122: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 80% | 0.39 | 15% | 85% | 13,390 | 29 | Dominated |
| MNH-123: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 80% | 0.44 | 13% | 87% | 11,554 | 38 | Dominated |
| MNH-124: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 80% | 0.51 | 12% | 88% | 16,164 | 31 | Dominated |
| MNH-125: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 80% | 0.51 | 11% | 89% | 12,124 | 42 | Dominated |
| MNH-126: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 80% | 0.60 | 10% | 90% | 16,473 | 36 | Dominated |
| MNH-127: Community newborn care package + Tetanus Toxoid | 80% | 0.25 | 34% | 66% | 9,559 | 26 | Dominated |
| MNH-128: Community-based pneumonia + Tetanus Toxoid | 80% | 0.10 | 28% | 72% | 9,049 | 11 | Dominated |
| MNH-129: Community-based pneumonia + ANC | 80% | 0.16 | 26% | 74% | 13,804 | 11 | 18 |
| MNH-130: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 80% | 0.24 | 30% | 70% | 14,067 | 17 | Dominated |
| MNH-131: Support for breastfeeding mothers + Tetanus toxoid | 80% | 0.25 | 33% | 67% | 14,983 | 17 | Dominated |
| MNH-132: Community newborn care package + ANC | 80% | 0.30 | 32% | 68% | 14,314 | 21 | Dominated |
| MNH-133: Community newborn care package + ANC + Community-based pneumonia | 80% | 0.29 | 29% | 71% | 18,822 | 15 | Dominated |
| MNH-134: Community newborn care package + ANC + Community-based pneumonia + SMNC | 80% | 0.51 | 23% | 77% | 27,144 | 19 | Dominated |
| MNH-135: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 80% | 0.37 | 31% | 69% | 22,188 | 17 | 26 |
| MNH-136: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 80% | 0.78 | 16% | 84% | 29,837 | 26 | Dominated |
| MNH-137: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 80% | 0.59 | 26% | 74% | 30,510 | 19 | Dominated |
| MNH-138: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 80% | 0.56 | 21% | 79% | 29,043 | 19 | Dominated |
| MNH-139: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 80% | 0.79 | 16% | 84% | 34,159 | 23 | Dominated |
| MNH-140: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 80% | 0.83 | 15% | 85% | 35,391 | 24 | Dominated |
| MNH-141: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 80% | 0.98 | 13% | 87% | 35,590 | 28 | Dominated |
| MNH-142: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 80% | 0.64 | 24% | 76% | 32,409 | 20 | 26 |
| MNH-143: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 80% | 0.28 | 28% | 72% | 17,759 | 16 | Dominated |
| MNH-144: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 80% | 0.98 | 17% | 83% | 38,525 | 25 | Dominated |
| MNH-145: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 80% | 0.83 | 15% | 85% | 35,391 | 24 | Dominated |
| MNH-146: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 80% | 0.29 | 31% | 69% | 13,252 | 22 | Dominated |
| MNH-147: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.12 | 14% | 86% | 38,801 | 29 | Dominated |
| MNH-148: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 80% | 1.00 | 13% | 87% | 40,506 | 25 | Dominated |
| MNH-149: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 80% | 0.81 | 15% | 85% | 35,526 | 23 | Dominated |
| MNH-150: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 80% | 0.87 | 14% | 86% | 35,454 | 25 | Dominated |
| MNH-151: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 80% | 0.85 | 14% | 86% | 35,985 | 24 | Dominated |
| MNH-152: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 80% | 1.19 | 14% | 86% | 44,873 | 27 | 44 |
| MNH-153: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 80% | 1.42 | 12% | 88% | 49,988 | 28 | Dominated |
| MNH-154: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 80% | 0.45 | 23% | 77% | 13,208 | 34 | Dominated |
| MNH-155: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.11 | 13% | 87% | 37,738 | 29 | Dominated |
| MNH-156: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 80% | 1.42 | 12% | 88% | 49,988 | 28 | 46 |
| MNH-157: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 80% | 1.29 | 12% | 88% | 44,936 | 29 | Dominated |
| MNH-158: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 80% | 1.24 | 13% | 87% | 45,008 | 27 | Dominated |
| MNH-159: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 80% | 1.53 | 11% | 89% | 50,051 | 31 | Dominated |
| MNH-160: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 80% | 1.47 | 11% | 89% | 50,124 | 29 | Dominated |
| MNH-161: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 80% | 1.50 | 11% | 89% | 50,583 | 30 | Dominated |
| MNH-162: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 80% | 1.60 | 11% | 89% | 50,622 | 32 | Dominated |
| MNH-163: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 80% | 1.57 | 11% | 89% | 50,187 | 31 | Dominated |
| MNH-164: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 80% | 1.65 | 10% | 90% | 50,757 | 32 | Dominated |
| MNH-165: Community newborn care package + Tetanus Toxoid + SMNC | 80% | 0.45 | 24% | 76% | 17,958 | 25 | Dominated |
| MNH-166: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 80% | 0.44 | 21% | 79% | 17,715 | 25 | Dominated |
| MNH-167: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 80% | 0.44 | 22% | 78% | 22,466 | 20 | Dominated |
| MNH-168: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 80% | 0.49 | 22% | 78% | 16,900 | 29 | Dominated |
| MNH-169: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 80% | 0.48 | 20% | 80% | 21,408 | 22 | Dominated |
| MNH-170: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 80% | 0.70 | 16% | 84% | 23,247 | 30 | Dominated |
| MNH-171: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 80% | 0.69 | 14% | 86% | 27,755 | 25 | Dominated |
| MNH-172: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 80% | 0.71 | 16% | 84% | 27,998 | 25 | Dominated |
| MNH-173: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 80% | 0.69 | 14% | 86% | 27,755 | 25 | Dominated |
| MNH-174: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 80% | 0.70 | 15% | 85% | 32,506 | 22 | Dominated |
| MNH-175: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 80% | 0.54 | 20% | 80% | 28,058 | 19 | Dominated |
| MNH-176: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 80% | 0.82 | 14% | 86% | 34,405 | 24 | Dominated |
| MNH-177: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 80% | 0.64 | 17% | 83% | 28,121 | 23 | Dominated |
| MNH-178: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 80% | 0.58 | 18% | 82% | 28,193 | 21 | Dominated |
| MNH-179: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 80% | 0.69 | 15% | 85% | 28,257 | 24 | Dominated |
| MNH-180: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.32 | 11% | 89% | 44,086 | 30 | Dominated |
| MNH-181: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.33 | 12% | 88% | 45,149 | 29 | Dominated |
| MNH-182: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 80% | 1.40 | 11% | 89% | 45,719 | 31 | Dominated |
| MNH-183: Community newborn care package | 95% | 0.19 | 44% | 56% | 5,909 | 32 | Dominated |
| MNH-184: Support for breastfeeding mothers | 95% | 0.20 | 42% | 58% | 12,351 | 16 | Dominated |
| MNH-185: Pre-eclampsia screening | 95% | 0.22 | 64% | 36% | 2,689 | 81 | Dominated |
| MNH-186: Tetanus toxoid | 95% | 0.26 | 54% | 46% | 5,442 | 47 | Dominated |
| MNH-187: Screening & treatment of asymptomatic bacteriuria | 95% | 0.20 | 70% | 30% | 1,660 | 119 | Dominated |
| MNH-188: Screening & treatment of syphilis | 95% | 0.20 | 68% | 32% | 1,313 | 156 | Dominated |
| MNH-190: Normal delivery by a skilled attendant | 95% | 0.38 | 48% | 52% | 5,531 | 68 | Dominated |
| MNH-191: Community-based case management for neonatal pneumonia | 95% | 0.00 | 69% | 31% | 5,304 | 1 | 1 |
| MNH-193: Normal delivery by a skilled attendant + Tetanus Toxoid | 95% | 0.51 | 38% | 62% | 8,090 | 63 | Dominated |
| MNH-194: Management of maternal sepsis | 95% | 0.23 | 2% | 98% | 133 | 1,715 | Dominated |
| MNH-195: Management of severe neonatal asphyxia | 95% | 0.22 | 81% | 19% | 444 | 501 | Dominated |
| MNH-196: Management of serious newborn infections | 95% | 0.40 | 44% | 56% | 6,637 | 61 | Dominated |
| MNH-197: Management of very low birth weight babies | 95% | 0.25 | 72% | 28% | 3,997 | 63 | Dominated |
| MNH-198: Manangement of neonatal jaundice | 95% | 0.22 | 82% | 18% | 116 | 1,890 | Dominated |
| MNH-199: Tetanus toxoid + Pre-eclampsia screening | 95% | 0.32 | 44% | 56% | 8,149 | 39 | Dominated |
| MNH-200: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 95% | 0.33 | 47% | 53% | 9,827 | 34 | Dominated |
| MNH-201: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 95% | 0.35 | 48% | 52% | 11,089 | 32 | Dominated |
| MNH-202: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 95% | 0.55 | 40% | 60% | 9,775 | 56 | Dominated |
| MNH-203: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 95% | 0.52 | 39% | 61% | 13,732 | 38 | Dominated |
| MNH-204: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 95% | 0.92 | 21% | 79% | 15,628 | 59 | Dominated |
| MNH-205: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 95% | 0.60 | 36% | 64% | 9,936 | 60 | Dominated |
| MNH-206: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 95% | 0.63 | 33% | 67% | 8,796 | 72 | Dominated |
| MNH-207: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 95% | 0.85 | 24% | 76% | 14,165 | 60 | Dominated |
| MNH-208: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 95% | 0.62 | 31% | 69% | 10,912 | 57 | Dominated |
| MNH-209: Management of vLBW + Management of serious newborn infections | 95% | 0.62 | 30% | 70% | 10,675 | 58 | Dominated |
| MNH-210: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 95% | 0.66 | 28% | 72% | 11,127 | 59 | Dominated |
| MNH-211: Emergency neonatal care | 95% | 0.70 | 27% | 73% | 11,260 | 63 | Dominated |
| MNH-212: ENC + Management of maternal sepsis | 95% | 0.97 | 20% | 80% | 11,377 | 86 | Dominated |
| MNH-213: Community newborn care package + Community-based pneumonia | 95% | 0.15 | 30% | 70% | 11,262 | 14 | Dominated |
| MNH-214: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 95% | 0.61 | 38% | 62% | 13,645 | 45 | Dominated |
| MNH-215: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 95% | 0.67 | 34% | 66% | 15,900 | 42 | Dominated |
| MNH-216: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 95% | 0.74 | 31% | 69% | 13,720 | 54 | Dominated |
| MNH-217: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 95% | 0.87 | 30% | 70% | 19,194 | 45 | Dominated |
| MNH-218: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 95% | 0.83 | 28% | 72% | 14,397 | 58 | Dominated |
| MNH-219: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 95% | 0.99 | 27% | 73% | 19,562 | 51 | Dominated |
| MNH-221: Community newborn care package + Tetanus Toxoid | 95% | 0.45 | 50% | 50% | 11,352 | 39 | Dominated |
| MNH-222: Community-based pneumonia + Tetanus Toxoid | 95% | 0.26 | 54% | 46% | 10,746 | 24 | Dominated |
| MNH-223: Community-based pneumonia + ANC | 95% | 0.36 | 49% | 51% | 16,393 | 22 | Dominated |
| MNH-224: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 95% | 0.41 | 45% | 55% | 16,705 | 25 | Dominated |
| MNH-225: Support for breastfeeding mothers + Tetanus toxoid | 95% | 0.45 | 49% | 51% | 17,793 | 25 | Dominated |
| MNH-227: Community newborn care package + ANC | 95% | 0.54 | 47% | 53% | 16,998 | 32 | Dominated |
| MNH-228: Community newborn care package + ANC + Community-based pneumonia | 95% | 0.51 | 43% | 57% | 22,351 | 23 | Dominated |
| MNH-229: Community newborn care package + ANC + Community-based pneumonia + SMNC | 95% | 0.82 | 39% | 61% | 32,234 | 26 | Dominated |
| MNH-230: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 95% | 0.76 | 52% | 48% | 26,348 | 29 | Dominated |
| MNH-232: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 95% | 1.18 | 28% | 72% | 35,431 | 33 | Dominated |
| MNH-233: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 95% | 1.08 | 47% | 53% | 36,230 | 30 | Dominated |
| MNH-235: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 95% | 0.89 | 36% | 64% | 34,489 | 26 | Dominated |
| MNH-236: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 95% | 1.23 | 27% | 73% | 40,563 | 30 | Dominated |
| MNH-237: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 95% | 1.30 | 25% | 75% | 42,027 | 31 | Dominated |
| MNH-240: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 95% | 1.48 | 22% | 78% | 42,263 | 35 | Dominated |
| MNH-241: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 95% | 1.14 | 44% | 56% | 38,486 | 30 | Dominated |
| MNH-242: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 95% | 0.49 | 41% | 59% | 21,089 | 23 | Dominated |
| MNH-243: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 95% | 1.59 | 32% | 68% | 45,749 | 35 | Dominated |
| MNH-244: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 95% | 1.30 | 25% | 75% | 42,027 | 31 | Dominated |
| MNH-245: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 95% | 0.52 | 46% | 54% | 15,736 | 33 | Dominated |
| MNH-246: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.76 | 29% | 71% | 46,076 | 38 | Dominated |
| MNH-247: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 95% | 1.51 | 22% | 78% | 48,101 | 31 | Dominated |
| MNH-248: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 95% | 1.22 | 26% | 74% | 42,188 | 29 | Dominated |
| MNH-249: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 95% | 1.29 | 25% | 75% | 42,102 | 31 | Dominated |
| MNH-250: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 95% | 1.29 | 26% | 74% | 42,733 | 30 | Dominated |
| MNH-251: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 95% | 1.87 | 27% | 73% | 53,286 | 35 | Dominated |
| MNH-252: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 95% | 2.22 | 24% | 76% | 59,361 | 37 | Dominated |
| MNH-253: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 95% | 0.74 | 41% | 59% | 15,684 | 47 | Dominated |
| MNH-254: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.74 | 28% | 72% | 44,814 | 39 | Dominated |
| MNH-255: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 95% | 2.22 | 24% | 76% | 59,361 | 37 | 85 |
| MNH-256: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 95% | 2.00 | 26% | 74% | 53,361 | 37 | Dominated |
| MNH-257: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 95% | 1.92 | 27% | 73% | 53,447 | 36 | Dominated |
| MNH-258: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 95% | 2.34 | 22% | 78% | 59,436 | 39 | Dominated |
| MNH-259: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 95% | 2.27 | 23% | 77% | 59,522 | 38 | Dominated |
| MNH-260: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 95% | 2.34 | 23% | 77% | 60,067 | 39 | 174 |
| MNH-261: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 95% | 2.44 | 22% | 78% | 60,113 | 41 | Dominated |
| MNH-262: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 95% | 2.39 | 22% | 78% | 59,597 | 40 | Dominated |
| MNH-263: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 95% | 2.49 | 21% | 79% | 60,274 | 41 | 710 |
| MNH-264: Community newborn care package + Tetanus Toxoid + SMNC | 95% | 0.75 | 42% | 58% | 21,326 | 35 | Dominated |
| MNH-265: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 95% | 0.70 | 38% | 62% | 21,037 | 33 | Dominated |
| MNH-266: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 95% | 0.72 | 39% | 61% | 26,679 | 27 | Dominated |
| MNH-267: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 95% | 0.81 | 39% | 61% | 20,069 | 40 | Dominated |
| MNH-268: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 95% | 0.78 | 36% | 64% | 25,422 | 31 | Dominated |
| MNH-269: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 95% | 1.09 | 29% | 71% | 27,606 | 40 | Dominated |
| MNH-270: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 95% | 1.06 | 26% | 74% | 32,959 | 32 | Dominated |
| MNH-271: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 95% | 1.11 | 30% | 70% | 33,248 | 33 | Dominated |
| MNH-272: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 95% | 1.06 | 26% | 74% | 32,959 | 32 | Dominated |
| MNH-273: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 95% | 1.08 | 28% | 72% | 38,601 | 28 | Dominated |
| MNH-274: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 95% | 0.86 | 35% | 65% | 33,318 | 26 | Dominated |
| MNH-275: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 95% | 1.27 | 24% | 76% | 40,856 | 31 | Dominated |
| MNH-276: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 95% | 0.98 | 30% | 70% | 33,394 | 29 | Dominated |
| MNH-277: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 95% | 0.91 | 33% | 67% | 33,480 | 27 | Dominated |
| MNH-278: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 95% | 1.03 | 29% | 71% | 33,555 | 31 | Dominated |
| MNH-279: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 2.02 | 24% | 76% | 52,352 | 39 | Dominated |
| MNH-280: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 2.04 | 25% | 75% | 53,614 | 38 | Dominated |
| MNH-281: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 95% | 2.13 | 24% | 76% | 54,291 | 39 | Dominated |
| MNH-282: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term | 95% | 1.42 | 36% | 64% | 42,305 | 34 | Dominated |
| MNH-283: Community newborn care package + Tetanus toxoid + Community-based pneumonia + SMNC + Management of vLBW | 95% | 0.97 | 47% | 53% | 30,675 | 32 | Dominated |
| MNH-284: Community newborn care package + Tetanus toxoid + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term | 95% | 1.32 | 36% | 64% | 36,750 | 36 | Dominated |
| MNH-285: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term + Treatment of severe PEE | 95% | 1.48 | 35% | 65% | 44,560 | 33 | Dominated |
| MNH-286: Community newborn care package + ANC + Community-based pneumonia + SMNC + ENC + Steroids pre-term + Treatment of severe PEE | 95% | 1.94 | 27% | 73% | 51,823 | 37 | Dominated |